Stock Events

Stock Events

Imagion Biosystems Limited 

$0.01
15
+$0+0% Tuesday 17:19

Statistics

Day High
0.02
Day Low
0.02
52W High
0.04
52W Low
0.01
Volume
30,000
Avg. Volume
905
Mkt Cap
5.46M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

28AugExpected
Q2 2022
Q3 2022
Q4 2022
Q2 2023
Q4 2023
Q1 2024
Q2 2024
-0.01
0.32
0.66
0.99
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-5.73MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IBXXF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GE Aerospace
GE
Mkt Cap325.25B
General Electric, through its healthcare division, competes in the imaging and diagnostics field, overlapping with Imagion Biosystems' focus on early cancer detection technologies.
Siemens
SIEGY
Mkt Cap206.65B
Siemens Healthineers offers a broad range of imaging and diagnostic equipment, directly competing with Imagion Biosystems in the medical imaging sector.
Koninklijke Philips N.V.
PHG
Mkt Cap27.14B
Philips is a major player in healthcare technology, including imaging systems and healthcare informatics, competing in the same space as Imagion Biosystems.
Thermo Fisher Scientific
TMO
Mkt Cap184.37B
Thermo Fisher Scientific provides analytical instruments and reagents, including for diagnostics and research, overlapping with Imagion Biosystems' technology in cancer detection.
Danaher
DHR
Mkt Cap134.19B
Illumina
ILMN
Mkt Cap18.49B
Boston Scientific
BSX
Mkt Cap91.83B
Boston Scientific is involved in medical devices and diagnostics, including interventional radiology, competing in the diagnostics and imaging market.
Abbott Laboratories
ABT
Mkt Cap174.29B
Abbott Laboratories offers a wide range of diagnostics and medical devices, including for cancer detection, making it a direct competitor.
Resmed
RMD
Mkt Cap33.41B
ResMed, while focused on sleep and respiratory care, also ventures into healthcare informatics, indirectly competing in the healthcare diagnostics market.
Bio-Rad Laboratories
BIO
Mkt Cap7.54B
Bio-Rad Laboratories provides clinical diagnostics and life science research products, competing in the diagnostics and research tools market.

About

Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis; and a joint development agreement with Global Cancer Technology, Inc. to develop GCT's novel nanoscintillator technology for the treatment of breast cancer. The company was incorporated in 2016 and is based in San Diego, California.
Show more...
CEO
Mr. Robert Romeo Proulx
Employees
11
Country
United States
ISIN
AU000000IBX6

Listings

OTC Link
US
IBXXF
AU
AU
IBX.AU

0 Comments

Share your thoughts

FAQ

What is Imagion Biosystems Limited stock price today?▼
The current price of IBXXF is $0.01 USD — it has increased by +0% in the past 24 hours. Watch Imagion Biosystems Limited stock price performance more closely on the chart.
What is Imagion Biosystems Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Imagion Biosystems Limited stocks are traded under the ticker IBXXF.
Is Imagion Biosystems Limited stock price growing?▼
IBXXF stock has risen by +0% compared to the previous week, the month change is a -25.33% fall, over the last year Imagion Biosystems Limited has showed a -53.33% decrease.
What is Imagion Biosystems Limited market cap?▼
Today Imagion Biosystems Limited has the market capitalization of 5.46M
What were Imagion Biosystems Limited earnings last quarter?▼
IBXXF earnings for the last quarter are -0 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Imagion Biosystems Limited revenue for the last year?▼
Imagion Biosystems Limited revenue for the last year amounts to 0 USD.
What is Imagion Biosystems Limited net income for the last year?▼
IBXXF net income for the last year is -5.73M USD.
How many employees does Imagion Biosystems Limited have?▼
As of April 13, 2026, the company has 11 employees.
In which sector is Imagion Biosystems Limited located?▼
Imagion Biosystems Limited operates in the Health & Wellness sector.
When did Imagion Biosystems Limited complete a stock split?▼
The last stock split for Imagion Biosystems Limited was on November 16, 2023 with a ratio of 1:40.
Where is Imagion Biosystems Limited headquartered?▼
Imagion Biosystems Limited is headquartered in Melbourne, United States.